Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other ...

A headache is a common occurrence for many of us, but for Effie Iemma , it was the first sign that she had glaucoma. "I had an eye test, just my normal routine eye ...

Glaucoma is often called the “silent thief of sight” because the disease can damage vision for years before people notice ...

A major international study led by Flinders University has identified a genetic contributor to juvenile glaucoma. Published today in the journal JAMA Ophthalmology, the study marks another important ...

Glaucoma is a group of eye conditions that can cause vision loss and damage to the optic nerve. Possible treatments include eye drops and surgery. Glaucoma is relatively common. It is most likely to ...

Charisse Brown, a 38-year-old Columbia, S.C., resident, talks about her journey with glaucoma and keratoconus, which led to vision loss in her left eye. Underinsured and not qualifying for Medicaid, ...

Many patients come in for an eye examination that they have been delaying for years, and we often discover severe glaucoma to an extent that treatment options are very limited. The damage is often so ...

Australian researchers studying glaucoma have had a breakthrough, identifying new genetic markers that increase the risk of developing the damaging eye disease. Glaucoma is the leading cause of ...

Synakis Corp., a Toronto-based biotechnology company developing ocular therapies for retinal disease and glaucoma, announced today the close of an oversubscribed CAD $2.6 million pre-seed financing ...

Glaucoma videos on social media may promote dangerous, unproven treatment options and frequently do not discuss any risks ...

These drugs improve blood flow and may have protective features for eyes ...

Ocular Therapeutix delivers ophthalmic therapies with hydrogel technology and a pipeline targeting retinal and glaucoma ...